■ Review Article cme ARTICLE A damantinoma of the long bones is a low-grade, slow-growing, primary malignant bone tumor composed of epithelial cells in a fi brous or osteofi brous stroma. 1, 2 It has a wide range of histological patterns. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Despite the considerable range of each histologic pattern, most current studies have shown that long bone adamantinoma appears to be of an epithelial nature. The tibial lesion's name comes from its somewhat similar histologic appearance to the more common odontogenic adamantinoma of the jaw bones. 18, 19 Despite the histological similarities there is no proof that these tumors have a similar histiogenetic origin. 19 Long bone adamantinomas can be divided in two main groups with distinct histological and radiographic features. The fi rst-classic adamantinoma-is characterized by an abundance of tumor cells and a destructive growth pattern. The second, differentiated adamantinoma, is characterized histologically by a predominance of an osteofi brous dysplasia-like pattern with a small, inconspicuous component of epithelial tumor elements. 12, 18, 19 Radiographically, classic adamantinomas are either intracortical or associated with complete cortical disruption, intramedullary involvement, and expansion beyond the periosteum into adjacent soft tissues, while differentiated adamantinomas are intracortical and often multicentric lesions. 12, 19, 20 This article discusses the epidemiology, clinicopathological and imaging features, diagnosis, treatment, and prognosis of adamantinoma of the long bones.
■ Review Article cme ARTICLE malignant bone tumors. [4] [5] [6] [7] [8] [9] 21 In 1986, Moon and Mori 2 performed a meta-analysis of 200 cases. In 1996, Unni 18 reported 36 cases in an analysis of 5641 primary malignant bone tumors from a single institution.
The literature suggests a slight male predominance. 1, 2, [4] [5] [6] [7] [8] [9] 21 Adamantinomas usually are diagnosed after skeletal maturity. Although 75% of the cases occur between the second and third decades of life, 18 adamantinomas have also been reported in older patients, as well as in children aged Ͻ14 years. 18, 22, 23 Differentiated adamantinomas tend to occur in younger patients. 18, 19 More than 90% of adamantinomas appear in the tibia, with fi bular involvement coexisting in 50% of the cases. 12, 18, 19 The tumor usually is located in the diaphysis and, less frequently, the tibial metaphysis. Rare cases of adamantinomas of the olecranon, the ribs, the radius, the spine, the metatarsus, and the humerus also have been reported.
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CLINICAL MANIFESTATIONS
A history of previous trauma or fracture occurring months or years prior to the onset of symptoms is reported in approximately 60% of patients. The most common presentation is of a gradually evolving mass associated with dull, insidious, aching pain. Bowing deformity of the tibia and pathologic fractures may occur. Advanced or recurrent lesions may be associated with soft-tissue involvement. 12, 18, 21 Severe paraneoplastic, humorally mediated hypercalcaemia, hypercalcaemic coma, and pancreatitis have been reported.
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IMAGING FEATURES
Radiographically, adamantinoma usually appears as a mixed lytic and sclerotic central lesion or multiple, sharply circumscribed lucencies with sclerosis of the intervening bone (Figure 1 ). This slowly growing, expansile tumor eventually causes endosteal scalloping and thinning, interruption, or destruction of the cortex without periosteal reaction. Moderate to severe anterior bowing deformity is common. 19, 20 Classical adamantinoma usually is intracortical with evidence of complete cortical disruption and intramedullary and soft-tissue involvement. Involvement of the anterolateral cortex of the tibia with multiple lucencies and sclerotic foci characterizes differentiated adamantinoma. These imaging features may be similar to those observed in osteofi brous dysplasia. 12, 18, 20 Technetium pyrophosphate bone scan shows intense increased uptake tracer accumulation, corresponding closely to the extent of the lesion. 18, 21, 36 In addition, bone scan may show a coexisting fi bular involvement.
Computed tomography reveals an osteolytic lesion with expansion and destruction of the cortex (Figure 2) , and probable extension to the surrounding soft tissues. 21, 37 Magnetic resonance imaging (MRI) is useful in providing information concerning the intramedullary and soft-tissue extent of the tumor.
9,20,36-38 On T1-weighted MRI, the lesion has a low intensity signal, whereas on T2-weighted MRI the signal is much brighter and does not diminish with the fat suppression technique.
In a study of 22 patients, two morphologic patterns were distinguished in MRI: a solitary, lobulated focus versus a pattern of multiple small modules in one or more foci; however, these characteristics were not related to the histologic subtype.
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HISTOLOGIC FEATURES
Histologically, adamantinoma is composed of epithelial islands in a spindle cell stroma. The relative amounts of the two components can vary considerably ( Figure  3 ). Several histologic variants have been 
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cme ARTICLE described corresponding to a variety of different epithelial cell patterns that can be found. Therefore, this range of morphologic patterns can mimic many primary or metastatic bone lesions.
21,39 A number of immunohistochemical and electron microscopic studies have shown adamantinoma to be of epithelial derivation. 1, [9] [10] [11] 36, [40] [41] [42] [43] [44] In some tumors the stromal component has a fi brous dysplsia-like appearance with or without scattered spicules of woven bone. 18, 19 
DIFFERENTIAL DIAGNOSIS
Because of its rarity and differing histological patterns, adamantinoma histologically may resemble epithelial metastasis, hemangioendothelioma, hemangiosarcoma, fi brous and osteofi brous dysplasia, nonossifying fi bromas, and chondromyxoid fi bromas. 18, 19, [44] [45] [46] [47] Clinical information such as patient age and history, as well as the location in the tibial diaphysis, may aid in diagnosis.
It is important to differentiate adamantinoma from osteofi brous dysplasia. 20 Adamantinoma generally is painful, is observed during adulthood, has different radiographic features, is progressive during adult age, and may expand into the soft tissues. However, osteofi brous dysplasia seldom progresses during childhood, and any progression of the lesion stops after puberty. Exceptional cases have been reported of adamantinoma that began during childhood and have radiographic features similar to osteofi brous dysplasia. [45] [46] [47] Adamantinoma must be suspected if a tibial lesion becomes painful or if it grows after puberty. In such cases, extensive biopsy from the most radiolucent areas is recommended. However, given the heterogeneity of the histology within different areas of adamantinomas, sampling errors are possible with limited biopsy specimens. These errors have led to reclassifi cation of these tumors from osteofi brous dysplasia to adamantinoma after repeat biopsy with adequate tissue.
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TREATMENT AND PROGNOSIS
Owing to the rarity of adamantinomas, data is insuffi cient concerning the safest and most effective treatment modality. These tumors are of low-grade malignancy and highly radioresistant. 48, 49 Thus surgery is the treatment of choice. Although limited experience with them has been reported, chemotherapy and radiation therapy have not been shown to be effective. 8 Operative treatment includes either surgical resection with wide margins and reconstruction of the segmental defect, 4, 5, 8, 9, 12, 18, 21, [50] [51] [52] or amputation. 1, 2, 5, 9 Limb reconstruction options include the use of allografts (intercalary, osteoarticular, or morselized), vascularized and nonvascularized fi bular autografts, metallic segmental implants, and distraction osteogenesis. 9 ,21,51,53 Intercalary reconstruction appears to be the most successful method (Figure 4 ). Qureshi et al 9 reported a limb salvage rate of 84%. They used allografts in 61% of the reconstructions after resection of adamantinomas of long bones. The majority were intercalary reconstructions. No differences in the effi cacy of different fi xation techniques were noted. Complications related to the reconstruction were unacceptably high (48% of patients), including nonunion (24%) and fracture of the allograft (23%). Vascularized fi bular grafts have been considered the best type of graft for large segmental bone defects after bone tumor resections. 54, 55 Local recurrence is common in inadequately treated patients. 12, 21, 56, 57 Wide operative margins are associated with a lower rate of local recurrence than marginal or intralesional margins. 8, 9, 24 However, a 18.6% rate of local recurrence at Figure 4 : AP (A) and lateral (B) plain radiographs after wide resection of the tumor and reconstruction using a 13 cm intercalary tibial allograft fi xed using a DCP plate and screws and autologous iliac bone grafting at the host bone allograft junction.
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■ Review Article cme ARTICLE 10 years has been reported after widemargin surgical excision of adamantinomas. 9 Local recurrences usually occur 5 to 15 years after primary excision of the tumor. Late local recurrences have been reported at 24 and 36 years after diagnosis. 21, 56 No statistically signifi cant difference between local recurrence rate and tumor stage, duration of symptoms, patient gender and age, type of biopsy, and type of grafting has been documented. 9, 12 Wide resection is also indicated for recurrent tumors. 56 The near-benign biology and slowgrowing nature of adamantinoma are refl ected in the good survival rates even after local recurrences and lung or regional lymph node metastases.
21,39,51 Late metastases may occur in 10%-30% of patients with adamantinomas, most frequently in the lungs, the regional lymph nodes, or the bones. 19 ,21,24,32-35 After wide margin surgical excision of the tumor or amputation, overall 10-year survival rates vary from 82% to 87%.
1,2,8,12
CONCLUSION
Adamantinoma of the long bones is a rare, primary, low-grade, slow-growing malignant bone tumor. It is expressed with a wide range of histological patterns. Histologically, the tumor is composed of an epithelial component surrounded by a fi brous stroma that may or may not contain spicules of woven bone. In the majority of cases, adamantinomas are located in the tibial diaphysis. Limb salvage with wide surgical resection and reconstruction or amputation is the most effective treatment. Local recurrence is associated with incomplete resection. Survival rates range from 82% to 87%. Late metastases, mainly to the lungs, may occur. 
Instructions
1. Review the stated learning objectives at the beginning of the CME article and determine if these objectives match your individual learning needs.
2. Read the article carefully. Do not neglect the tables and other illustrative materials, as they have been selected to enhance your knowledge and understanding.
3. The following quiz questions have been designed to provide a useful link between the CME article in the issue and your everyday practice. Read each question, choose the correct answer, and record your answer on the CME REGISTRATION FORM at the end of the quiz.
4. Type or print your full name and address and your date of birth in the space provided on the CME Registration Form.
5.
Complete the Evaluation portion of the CME Regi stration Form. Forms and quizzes cannot be processed if the Evaluation portion is incomplete. The Evaluation portion of the CME Registration Form will be separated from the quiz upon receipt at ORTHOPEDICS. Your evaluation of this activity will in no way affect the scoring of your quiz.
6. Send the completed form, with your $15 payment (check or money order in US dollars drawn on a US bank, or credit card information) to: ORTHOPEDICS CME Quiz, PO Box 36, Thorofare, NJ 08086, OR take the quiz on-line. Visit www. ORTHOSuperSite.com for details.
7. Your answers will be graded, and you will be advised whether you have passed or failed. Unanswered questions will be considered incorrect. A score of at least 80% is required to pass. If a passing score is achieved, Vindico Medical Education will issue an AMA PRA Category 1™ certificate within 4-6 weeks.
8. Be sure to mail the CME Registration Form on or before the deadline listed. After that date, the quiz will close. CME Registration Forms received after the date listed will not be processed.
CME ACCREDITATION
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and ORTHOPEDICS. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians. Vindico Medical Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CME activity is primarily targeted to orthopedic surgeons, hand surgeons, head and neck surgeons, trauma surgeons, physical medicine specialists, and rheumatologists. There is no specific background requirement for participants taking this activity.
FULL DISCLOSURE POLICY
In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
UNLABELED AND INVESTIGATIONAL USAGE
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. cme QUIZ
6.
Which of the following is true regarding biopsy of suspected tibia lesions for adamantinomas of the long bones?
